Clincosm LogoSign in Get a demo

Myelodysplastic Syndrome

Showing 76 - 100 of 489
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • Haploidentical hematopoietic cell transplantation (haploHCT)
  • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
  • (no location specified)
Jul 13, 2022

Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 11, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Trial in Zhengzhou (6MW3211

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • 6MW3211 injection with Intravenous Infusion
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 2, 2022

Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

Not yet recruiting
  • Allogeneic Stem Cell Transplant Candidate
  • +4 more
  • Cellular therapy product
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 1, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (MultiTAA-specific T cells)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • MultiTAA-specific T cells
  • Houston, Texas
  • +1 more
May 31, 2022

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in Houston (Azacitidine, Quizartinib)

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
May 23, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • ATIR101
  • +3 more
  • Duarte, California
  • +41 more
Apr 28, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle

Recruiting
  • Acute Biphenotypic Leukemia
  • +5 more
  • Dilanubicel
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 11, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
May 16, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • SY-1425 (tamibarotene)
  • +2 more
  • Hartford, Connecticut
  • +25 more
May 4, 2022

Minimal Residual Disease of Acute Myelogenous Leukemia or High

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
    • Rochester, New York
      University of Rochester Medical Center
    May 3, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine and

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Decitabine and Cedazuridine
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 19, 2022

    Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

    Terminated
    • Related Donors Donating PBSC to a Family Member
    • +4 more
    • MGTA-145
    • Plerixafor
    • Duarte, California
    • +7 more
    Apr 13, 2022

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Tampa, Florida
    • +8 more
    Apr 5, 2022

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

    Completed
    • Acute Lymphoblastic Leukemia
    • +5 more
    • Radiation
    • +3 more
    • New Hyde Park, New York
      Cohen Children's Medical Center
    Apr 6, 2022

    Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

    Completed
    • Chronic Myelogenous Leukemia
    • +9 more
    • Atlanta, Georgia
      Northside Hospital
    Apr 4, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Boston (RAD001, PKC412)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Boston, Massachusetts
    • +2 more
    Mar 28, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Duarte (Decitabine, Pembrolizumab,

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Duarte, California
      City of Hope Comprehensive Cancer Center
    Mar 9, 2022

    Intravenous Busulfan And Fludarabine Myeloablative Conditioning

    Completed
    • Acute Myeloid Leukemia
    • +3 more
      • (no location specified)
      Mar 16, 2022

      Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

      No longer available
      • Chronic Myeloid Leukemia
      • +2 more
      • G-CSF mobilized CD34+ selected cells for transplantation
      • Atlanta, Georgia
        Emory University/Winship Cancer Institute
      Feb 28, 2022

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Sacramento (Lenalidomide)

      Completed
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • Sacramento, California
        University of California Davis
      Mar 8, 2022

      Survivors of Transplant, CREST Study

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +6 more
      • Bioelectric Impedance Analysis
      • +7 more
      • Duarte, California
        City of Hope Comprehensive Cancer Center
      Mar 7, 2022

      Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • FT-2102 (olutasidenib)
      • +2 more
      • Los Angeles, California
      • +59 more
      Mar 2, 2022

      Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)

      Active, not recruiting
      Has Results
      • Anemia
      • +3 more
      • Epoetin Alfa
      • +2 more
      • Birmingham, Alabama
      • +512 more
      Mar 1, 2022

      Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

      Recruiting
      • Acute Myeloid Leukemia
      • +10 more
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Mar 1, 2022